Predicting Cardiovascular Risk in Type 2 Diabetes: the Heterogeneity Challenges

M. Odette Gore, Darren K McGuire, Ildiko Lingvay, Julio Rosenstock

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Type 2 diabetes mellitus has reached epidemic proportions around the world, and the increase in cardiovascular risk attributable to diabetes estimated to range from 2- to 4-fold poses grave public health concern. Though in some contexts type 2 diabetes has been equated with coronary heart disease equivalent risk, there is considerable evidence that incremental cardiovascular risk does not uniformly affect all people with type 2 diabetes. This heterogeneity in cardiovascular risk is multifactorial and only partially understood but is a key consideration for our understanding of the nexus of diabetes and cardiovascular disease and for the development of optimal and individualized cardiovascular risk reduction strategies. This review provides a brief synopsis of the concept of cardiovascular risk heterogeneity in diabetes, including epidemiologic evidence, discussion of established and potential determinants of heterogeneity, and clinical, research, and regulatory implications.

Original languageEnglish (US)
Article number54
JournalCurrent Cardiology Reports
Volume17
Issue number7
DOIs
StatePublished - Jul 4 2015

Fingerprint

Type 2 Diabetes Mellitus
Risk Reduction Behavior
Coronary Disease
Cardiovascular Diseases
Public Health
Research

Keywords

  • Cardiovascular disease
  • Cardiovascular risk factors
  • Diabetes mellitus
  • Macrovascular complications

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Predicting Cardiovascular Risk in Type 2 Diabetes : the Heterogeneity Challenges. / Gore, M. Odette; McGuire, Darren K; Lingvay, Ildiko; Rosenstock, Julio.

In: Current Cardiology Reports, Vol. 17, No. 7, 54, 04.07.2015.

Research output: Contribution to journalArticle

@article{1689276f78e545109a9a04d08e9daafe,
title = "Predicting Cardiovascular Risk in Type 2 Diabetes: the Heterogeneity Challenges",
abstract = "Type 2 diabetes mellitus has reached epidemic proportions around the world, and the increase in cardiovascular risk attributable to diabetes estimated to range from 2- to 4-fold poses grave public health concern. Though in some contexts type 2 diabetes has been equated with coronary heart disease equivalent risk, there is considerable evidence that incremental cardiovascular risk does not uniformly affect all people with type 2 diabetes. This heterogeneity in cardiovascular risk is multifactorial and only partially understood but is a key consideration for our understanding of the nexus of diabetes and cardiovascular disease and for the development of optimal and individualized cardiovascular risk reduction strategies. This review provides a brief synopsis of the concept of cardiovascular risk heterogeneity in diabetes, including epidemiologic evidence, discussion of established and potential determinants of heterogeneity, and clinical, research, and regulatory implications.",
keywords = "Cardiovascular disease, Cardiovascular risk factors, Diabetes mellitus, Macrovascular complications",
author = "Gore, {M. Odette} and McGuire, {Darren K} and Ildiko Lingvay and Julio Rosenstock",
year = "2015",
month = "7",
day = "4",
doi = "10.1007/s11886-015-0607-7",
language = "English (US)",
volume = "17",
journal = "Current Cardiology Reports",
issn = "1523-3782",
publisher = "Current Medicine Group",
number = "7",

}

TY - JOUR

T1 - Predicting Cardiovascular Risk in Type 2 Diabetes

T2 - the Heterogeneity Challenges

AU - Gore, M. Odette

AU - McGuire, Darren K

AU - Lingvay, Ildiko

AU - Rosenstock, Julio

PY - 2015/7/4

Y1 - 2015/7/4

N2 - Type 2 diabetes mellitus has reached epidemic proportions around the world, and the increase in cardiovascular risk attributable to diabetes estimated to range from 2- to 4-fold poses grave public health concern. Though in some contexts type 2 diabetes has been equated with coronary heart disease equivalent risk, there is considerable evidence that incremental cardiovascular risk does not uniformly affect all people with type 2 diabetes. This heterogeneity in cardiovascular risk is multifactorial and only partially understood but is a key consideration for our understanding of the nexus of diabetes and cardiovascular disease and for the development of optimal and individualized cardiovascular risk reduction strategies. This review provides a brief synopsis of the concept of cardiovascular risk heterogeneity in diabetes, including epidemiologic evidence, discussion of established and potential determinants of heterogeneity, and clinical, research, and regulatory implications.

AB - Type 2 diabetes mellitus has reached epidemic proportions around the world, and the increase in cardiovascular risk attributable to diabetes estimated to range from 2- to 4-fold poses grave public health concern. Though in some contexts type 2 diabetes has been equated with coronary heart disease equivalent risk, there is considerable evidence that incremental cardiovascular risk does not uniformly affect all people with type 2 diabetes. This heterogeneity in cardiovascular risk is multifactorial and only partially understood but is a key consideration for our understanding of the nexus of diabetes and cardiovascular disease and for the development of optimal and individualized cardiovascular risk reduction strategies. This review provides a brief synopsis of the concept of cardiovascular risk heterogeneity in diabetes, including epidemiologic evidence, discussion of established and potential determinants of heterogeneity, and clinical, research, and regulatory implications.

KW - Cardiovascular disease

KW - Cardiovascular risk factors

KW - Diabetes mellitus

KW - Macrovascular complications

UR - http://www.scopus.com/inward/record.url?scp=84930621074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930621074&partnerID=8YFLogxK

U2 - 10.1007/s11886-015-0607-7

DO - 10.1007/s11886-015-0607-7

M3 - Article

C2 - 26031671

AN - SCOPUS:84930621074

VL - 17

JO - Current Cardiology Reports

JF - Current Cardiology Reports

SN - 1523-3782

IS - 7

M1 - 54

ER -